Soleno Therapeutics, Inc. Share Price & Technical Analysis
SLNO · $53.01
Healthcare / Biotechnology
$53.01
Soleno Therapeutics, Inc., biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is VYKAT XR, an extended-release tablets for the treatment of Prader-Willi Syndrome. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeuti…
Price chart
Seasonality
May has 2 positive and 3 negative years (last 5 years shown)
0% return in May, 16% avg return in past 3 year May month.
16% return in 2026, 236% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -18% | -2% | -19% | 55% | 0% | – | – | – | – | – | – | – | 16% |
| 25 | 12% | 0% | 46% | 7% | -2% | 14% | 4% | -21% | -1% | 1% | -26% | -7% | 27% |
| 24 | 15% | 2% | -11% | 5% | -6% | -3% | 19% | 1% | 2% | 9% | -6% | -15% | 13% |
| 23 | 38% | -31% | 5% | 62% | 56% | -19% | 21% | -2% | 490% | -16% | 26% | 38% | 668% |
| 22 | -17% | -14% | -33% | -12% | -20% | 8% | -4% | -12% | -23% | -44% | 10% | 67% | -94% |
Monthly return % by calendar month · historical pattern, not a forecast
Weak · Emerging · Strong
Soleno Therapeutics, Inc., biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is VYKAT XR, an extended-release tablets for the treatment of Prader-Willi Syndrome. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is headquartered in Redwood City, California.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$2.76B
P/E ratio
27.44
52W high
$90.32
52W low
$29.43
Volume
49,68,834
Beta
-2.22
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Soleno Therapeutics, Inc. share price today?
- Soleno Therapeutics, Inc. (SLNO) last traded around $53.01 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does SLNO have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for SLNO. Download the app for real-time alerts.
- How can I analyze Soleno Therapeutics, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.